Compound ID | 2261
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Fatty acid synthesis inhibitor |
| Target Pathogen: | Active against Staphylococcaceae; alters fatty acid composition of Staphylococcus aureus |
| Description: | Natural product from a soil actinomycete AA4; decreases murine S. aureus skin infection but acted slower than mupirocin (control) |
| Year first mentioned: | 2018 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/146684601 |
| Citation: | https://www.pnas.org/doi/10.1073/pnas.1807613115 |